4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Pregnancy‐associated mortality due to cardiovascular disease: Impact of hypertensive disorders of pregnancy

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Reported rates of maternal mortality in the United States have been staggeringly high and increasing, and cardiovascular disease (CVD) is a chief contributor to such deaths. However, the impact of hypertensive disorders of pregnancy (HDP) on the short‐term risk of cardiovascular death is not well understood.

          Objectives

          To evaluate the association between HDP (chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and superimposed preeclampsia) and pregnancy‐associated mortality rates (PMR) from all causes, CVD‐related causes both at delivery and within 1 year following delivery.

          Methods

          We used the Nationwide Readmissions Database (2010–2018) to examine PMRs for females 15–54 years old. International Classification of Disease 9 and 10 diagnosis codes were used to identify pregnancy‐associated deaths due to HDP and CVD. Discrete‐time Cox proportional hazards regression models were used to calculate adjusted hazard ratios (HR) and 95% confidence intervals (CI) for mortality at delivery (0 days) and at <30, <60, <90, <180, and <365 days after delivery in relation to HDP.

          Results

          Of 33,417,736 hospital deliveries, the rate of HDP was 11.0% ( n = 3,688,967), and the PMR from CVD was 6.4 per 100,000 delivery hospitalisations ( n = 2141). Compared with normotensive patients, HRs for CVD‐related PMRs increased with HDP severity, reaching over 58‐fold for eclampsia patients. HRs were higher for stroke‐related (1.2 to 170.9) than heart disease (HD)‐related (0.99 to 39.8) mortality across all HDPs. Except for gestational hypertension, the increased risks of CVD mortality were evident at delivery and persisted 1 year postpartum for all HDPs.

          Conclusions

          HDPs are strong risk factors for pregnancy‐associated mortality due to CVD at delivery and within 1 year postpartum; the risks are stronger for stroke than HD‐related PMR. While absolute PMRs are low, this study supports the importance of extending postpartum care beyond the traditional 42‐day postpartum visit for people whose pregnancies are complicated by hypertension.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: not found
          • Article: not found

          Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.

          , (2013)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222.

            (2020)
            Hypertensive disorders of pregnancy constitute one of the leading causes of maternal and perinatal mortality worldwide. It has been estimated that preeclampsia complicates 2-8% of pregnancies globally (). In Latin America and the Caribbean, hypertensive disorders are responsible for almost 26% of maternal deaths, whereas in Africa and Asia they contribute to 9% of deaths. Although maternal mortality is much lower in high-income countries than in developing countries, 16% of maternal deaths can be attributed to hypertensive disorders (). In the United States, the rate of preeclampsia increased by 25% between 1987 and 2004 (). Moreover, in comparison with women giving birth in 1980, those giving birth in 2003 were at 6.7-fold increased risk of severe preeclampsia (). This complication is costly: one study reported that in 2012 in the United States, the estimated cost of preeclampsia within the first 12 months of delivery was $2.18 billion ($1.03 billion for women and $1.15 billion for infants), which was disproportionately borne by premature births (). This Practice Bulletin will provide guidelines for the diagnosis and management of gestational hypertension and preeclampsia.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

                Bookmark

                Author and article information

                Contributors
                Journal
                Paediatric and Perinatal Epidemiology
                Paediatric Perinatal Epid
                Wiley
                0269-5022
                1365-3016
                March 2024
                February 20 2024
                March 2024
                : 38
                : 3
                : 204-215
                Affiliations
                [1 ] Division of Epidemiology and Biostatistics, Department of Obstetrics, Gynecology, and Reproductive Sciences Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey USA
                [2 ] Division of Maternal‐Fetal Medicine, Department of Obstetrics and Gynecology, Grossman School of Medicine New York University New York City New York USA
                [3 ] Department of Obstetrics and Gynaecology University of British Columbia and the Children's and Women's Hospital and Health Centre of British Columbia Vancouver British Columbia Canada
                [4 ] School of Population and Public Health University of British Columbia Vancouver British Columbia Canada
                [5 ] Cardiovascular Institute of New Jersey Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey USA
                [6 ] Department of Medicine Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey USA
                [7 ] Department of Biostatistics and Epidemiology Rutgers School of Public Health Piscataway New Jersey USA
                Article
                10.1111/ppe.13055
                27cb9bb8-8eb7-49a0-ade9-6ba19f91ef04
                © 2024

                http://creativecommons.org/licenses/by/4.0/

                History

                Comments

                Comment on this article